Skip to main content

News Archive

News Archive - Susanne Clara Bard

Virtual Cells Built from 4D AI Models and “Digital Twins” Could Speed Up Drug Discovery

UC SanDiego researchers are using AI and "virtual cells" based on 4D movies to predict how cells will respond to drugs, which could speed up drug discovery for cancer, Alzheimer’s and more.

Blood Protein Linked to Lower Risk of Depression and PTSD After Traumatic Brain Injury

A new UC San Diego and San Diego VA study has found that U.S. Marines with higher natural anti-NMDAR1 antibody levels had ~25% lower depression and 22% lower PTSD symptoms after traumatic brain injury — a possible built-in resilience marker.

From Wearable Sensors to Printed Placentas

Maternal and fetal health researchers team up with engineers to improve pregnancy outcomes.

Unleashing Project CRASHCART

Expert team at UC San Diego aims to keep hospital systems running when cybercriminals attack.

UC San Diego Receives $12.3 Million Grant to Study the Intersection of HIV and Methamphetamine Use

UC San Diego has launched Brain-FRAMe, an innovative program integrating neuroscience and immunology to improve brain health and clinical care for people living with HIV and methamphetamine use disorder.

Scientists Uncover Cellular Mechanism Driving Both Rare Childhood Dementia and Alzheimer’s Disease

UC San Diego researchers have found a "genetic switch" triggering neurodegeneration in both a rare childhood dementia and Alzheimer's disease, pointing to new drug targets in the waste-processing system within the brain’s immune cells.

Personalized Gene Therapy Helps Teen with Rare Form of Severe Epilepsy Walk Independently

UC San Diego researchers and their colleagues designed short strands of DNA to target protein production by disease-causing mutations, dramatically reducing seizures and sparking developmental gains, helping one teenager walk independently.

UC San Diego Moores Cancer Center Receives Prestigious $25 Million Grant

The grant provides continuing support for the Comprehensive Cancer Center’s cutting‑edge research and increases access to innovative cancer therapies across the San Diego region.

Study: Popular GLP-1 Drug May Slow Down Biological Aging

A study by UC San Diego researchers and their colleagues has found that semaglutide slows down the accumulation of biological aging markers in the DNA of adults with HIV, pointing to the potential of GLP‑1 receptor agonists to help prevent age‑related diseases.

Search UC San Diego Today